Tamara has over 25 years of clinical research experience in pharmacology and therapeutic areas including oncology, metabolic disorders, cardiology, and dermatology. A distinguished leader in Early Phase, she has worked in a Phase I unit in Australia and with Australian-based CROs. Her expertise and deep passion guide clients to accelerate their early-phase research and transform promising ideas into groundbreaking medical advancements. As Global Head of Early Phase Research, she is dedicated to ensuring that studies are conducted with precision, efficiency, and the highest scientific and ethical standards. Her commitment to excellence and strategic vision make her a trusted partner in bringing new therapies to life.